In this study, the regulatory mechanism of the ula (utilization of L-ascorbic acid) operon, putatively responsible for transport and utilization of ascorbic acid in Streptococcus pneumoniae D39 strain, is studied. β-galactosidase assay data demonstrate that the expression of the ula operon is increased in the presence of ascorbic acid, as compared to the effects of other sugar sources, including glucose. The ula operon consists of nine genes, including a transcriptional regulator UlaR, and is transcribed as a single transcriptional unit. We demonstrate the role of the transcriptional regulator UlaR as a transcriptional activator of the ula operon in the presence of ascorbic acid and show that activation of the ula operon genes by UlaR is CcpA-independent. Furthermore, we predict a 16-bp regulatory site (5'-AACAGTCCGCTGTGTA-3') for UlaR in the promoter region of ulaA. Deletion of the halfor full UlaR regulatory site in the PulaA confirmed that the UlaR regulatory site present in PulaA is functional.
Introduction
Carbohydrate metabolism/utilization and their proper regulation play a key role in the survival of prokaryotes, since carbohydrate sources are the most common means of energy that are required to produce the essential nucleotides, cofactors and other indispensable metabolites for growth (116, 117) . A number of nutrients available to bacteria, including ascorbic acid, can be used as putative carbon sources in addition to the preferred carbon sources. Utilization of ascorbic acid as carbon source has been studied in many bacteria including Escherichia coli, Klebsiella pneumoniae and Enterococcus faecalis (166) (167) (168) (169) . In E. coli, ascorbic acid utilization is carried out by the ula gene cluster that is organized into two operons i.e. the ulaG operon that encodes L-ascorbate-6-P-lactonase and the ulaABCDEF operon that codes for the L-ascorbate-specific phosphotransferase system (UlaABC) and three catabolic enzymes (UlaDEF) (139, 169, 170) . Ascorbic acid is taken up and phosphorylated into L-ascorbate-6-P by the PTS (phosphotransferase system) components (UlaABC) and converted into 3-keto-L-gulonate-6-P by UlaG in E. coli (169) (170) (171) . UlaDEF are supposed to carry out the decarboxylation and epimerase activity on 3-keto-L-gulonate-6-P (169). Thus, this chain of enzymatic reactions in E. coli produces D-xylulose-5-phosphate ascorbate from 3-keto-L-gulonate-6-P which is further metabolized by the pentose phosphate pathway (169) (170) (171) . The ula gene cluster in E. coli is repressed by the DeoR-family transcriptional repressor UlaR in the absence of ascorbic acid by binding co-operatively to four operator sites located in two pairs in ulaG and ulaA promoters (139).
Streptococcus pneumoniae is a low-GC Gram-positive human pathogen that has the ability to utilize different sources of carbohydrates (88, 156, 95, 67, 102, 106) . The S. pneumoniae D39 strain possesses an operon that has high sequence similarity to the ula gene cluster present in E. coli, K. pneumoniae and other bacteria. The ula operon in S. pneumoniae consists of nine genes (spd_1839-47) including a transcriptional regulator UlaR. In this study, we investigate the regulatory mechanism of the ula operon by UlaR in the presence of ascorbic acid in S. pneumoniae strain D39. Using microarray analysis and transcriptional lacZ studies, we demonstrate that the transcriptional regulator UlaR acts as a transcriptional activator for expression of the ula operon genes in the presence of ascorbic acid and that UlaR-dependent regulation of ula operon is CcpA (carbon catabolite protein A)-independent.
Furthermore, we predict and verify a 16bp regulatory site in the promoter region of the ula operon for the transcriptional activator UlaR.
Materials and Methods

Bacterial strains, growth conditions and DNA manipulation
Bacterial strains and plasmids used in this study are listed in Table- 1. S. pneumoniae D39 strain (147) was grown as described before (106). For β-galactosidase assays, derivatives of the S. pneumoniae D39 strain were grown in M17 medium (172) (composed of pancreatic digest of casein, soy peptone, beef extract, yeast extract and minerals) supplemented with different sugars (arabinose, cellobiose, dextrose, fructose, fucose, glucose, galactose, ascorbic acid, lactose, maltose, mannitol, mannose, melibiose, sorbitol, trehalose and xylose) with concentrations mentioned in the Results section. For selection on antibiotics, the medium was supplemented with the following concentrations of antibiotics: tetracycline, 2.5 µg/ml for S. pneumoniae; and ampicillin, 100 µg/ml for E. coli. All bacterial strains used in this study were stored in 10% (v/v) glycerol at -80°C.
All DNA manipulations in this study were done as described before (146). For PCR amplification, chromosomal DNA of S. pneumoniae D39 (147) was used. Primers used in this study are based on the sequence of the D39 genome (147) and listed in Table- 2. 
Construction of an ulaR mutant
A markerless ulaR mutant (MA300) was constructed in S. pneumoniae D39 using pORI280, as described before (146). Primer pairs ulaR-1/ulaR-2 and ulaR-3/ulaR-4 were used to generate PCR fragments of the left and right flanking regions of ulaR. Mutants were further examined for the presence of the ulaR deletion by PCR and DNA sequencing.
Construction of promoter lacZ-fusions and β-galactosidase assays
Chromosomal transcriptional lacZ-fusions to the promoter region of ulaA (spd_1847), ulaC (spd_1845) and ulaG (spd_1840) were constructed in the integration plasmid pPP2 (149) via double crossover in the bgaA locus with the primer pairs mentioned in Table-2, resulting in pMA301-03. These constructs were subsequently introduced into the wild-type strain D39 resulting in MA301, MA302 and MA303, respectively. pMA301 was also introduced in the ∆ulaR and ∆ccpA strain resulting in MA304 and MA308, respectively.
Similarly, the following subclones of PulaA were made in pPP2 (149) using primers pairs mentioned in Table-2 UlaR regulatory site) resulting in plasmids pMA304-6, respectively. These constructs were introduced into D39 wild-type resulting in strains MA305, MA306 and MA307, respectively.
All plasmid constructs were checked by PCR and DNA sequencing.
β-galactosidase assays were performed as described before (146, 150) , using cells that were grown in M17 medium with appropriate carbon sources as mentioned in the Results section. The cells were harvested for β-galactosidase assay in their respective mid-exponential growth phase. 
Microarray analysis and Reverse transcription (RT)-PCR
To analyze the effect of the ulaR deletion on the transcriptome of S. pneumoniae, the D39 wild-type strain and its mutant (∆ulaR) strain were grown in replicate in AM17 (10mM Ascorbic acid + M17) medium and harvested at their respective mid-exponential growth phases. All other procedures regarding the DNA microarray experiment were performed as described previously (151).
To confirm that the ula operon is transcribed as one transcriptional unit, we performed RT-PCR reactions as described before (106) on all regions (IR-I to IR-VIII) between genes present in ula operon with primer pairs mentioned in Table-2 
Microarray data analysis
DNA microarray data were analyzed as previously described (151, 174) . For the identification of differentially expressed genes a Bayesian p-value of <0.001 and a fold change cut-off 3 was applied. Microarray data have been submitted to GEO under the accession number GSE61649. medium. This data not only suggests that the ula locus is organized in one transcriptional unit spanning the spd_1839-47 region, but also indicates the role of ascorbic acid as an inducer for this transcriptional unit. To further confirm that the ula locus is transcribed as a single transcriptional unit, we performed reverse transcriptase (RT)-PCR (with the primer pairs mentioned in Table- 2) for all intergenic regions between genes (IR-I to IR-VIII) present in ula locus (Figure-1A) . RT-PCR data also confirmed that the ula locus is transcribed as one transcriptional unit, originating from the promoter of ulaA (Figure-1) and from now on we will call this locus the ula operon.
Results
Ascorbic acid induces, while glucose and other sugars tested diminish, the expression of the ula operon
To further demonstrate the role of ascorbic acid in regulation of ula operon, the S.
pneumoniae D39 wild-type strain containing PulaA-lacZ was grown in the presence of various sugars in M17 medium and subsequently β-galactosidase assays were performed. The results indicate that the expression of PulaA-lacZ is highest in the presence of ascorbic acid and much lower in the presence of all other tested sugars including glucose (Table-3 ). This data confirms that in our tested conditions, ascorbic acid activates the expression of the ula operon and other tested carbon sources do not play a role in the activation of PulaA-lacZ. We further investigated the effect of ascorbic acid on the expression of PulaA-lacZ in the presence of glucose. We performed β-galactosidase assays with PulaA-lacZ at a constant concentration of glucose with increasing concentrations of ascorbic acid in the medium (Table-4 ).
Our β-galactosidase assay data revealed that glucose prevents the transcription of the ula operon even in the presence of ten time's higher concentrations of ascorbic acid (10mM) at a constant concentration of glucose (1mM). CcpA mediates the repression of genes involved in the utilization of non-preferred sugars in the presence of the glucose by binding to Catabolite Repression Elements (cre boxes) found in the promoter regions of CcpA targets.
To investigate the role of CcpA in the glucose-dependent repression of the ula operon in the presence of ascorbic acid, we analyzed the promoter region of ulaA to find a putative cre box.
We could not find any cre box in the promoter region of ulaA, which excludes the possible role of CcpA in the regulation of the ula operon. To confirm this further, we transformed
PulaA-lacZ into the ∆ccpA strain. The results of our β-galactosidase assay with PulaA-lacZ in 
UlaR acts as a transcriptional activator of the ula operon in the presence of ascorbic acid in S. pneumoniae
To elucidate the role of UlaR in the regulation of ula operon, we created a clean markerless knockout of ulaR (MA300) in S. pneumoniae D39 wild-type and introduced
PulaA-lacZ in the ∆ulaR strain to perform the β-galactosidase assay. No expression of PulaA-lacZ was observed in the ∆ulaR strain compared to the wild-type strain even in the presence of ascorbic acid (Figure-2B) . This data suggests the role of UlaR as a transcriptional activator of the ula operon in the presence of ascorbic acid. To further explore the effect of ulaR deletion on the transcriptome of S. pneumoniae D39 and to find more targets of UlaR, we decided to perform microarray analysis with the ∆ulaR strain. 
DNA microarray analysis of the ulaR mutant
To study the impact of ulaR deletion on the whole transcriptome of S. pneumoniae, the D39 wild-type strain was compared to D39 ∆ulaR grown in AM17 (10mM Ascorbic acid + M17) medium. AM17 medium was used to perform transcriptomics because our βgalactosidase assay with PulaA-lacZ in ∆ulaR suggested that UlaR putatively acts as a transcriptional activator of the ula operon in the presence of ascorbic acid. The changes in gene expression in S. pneumoniae D39 due to the deletion of ulaR in the presence of ascorbic acid are summarized in Table- 5. Ascorbate-specific PTS system, IIC component, UlaA -9.5
The expression of ulaR was seven times downregulated in the ∆ulaR confirming the deletion of ulaR in ∆ulaR strain. The ula operon was the only operon that was highly downregulated in the ∆ulaR strain after applying the criteria of ≥ 3.0-fold difference as the threshold change and a P value < 0.001 was chosen. Downregulation of the ula operon in the absence of ulaR confirms the role of UlaR as a transcriptional activator of the ula operon in the presence of ascorbic acid and also demonstrates that the ula operon is the only target of UlaR in the presence of ascorbic acid. Moreover, this data is also in accordance with our βgalactosidase data mentioned above. We decided to further explore the regulatory site of UlaR in PulaA.
Prediction of an UlaR regulatory site in PulaA
A 16-bp sequence (5'-AACAGTCCGCTGTGTA-3') located upstream of the ula operon of S. pneumoniae D39 wild-type was predicted by using a MEME motif sampler search (178) (Figure-3(A) . agalactiae, S. dysgalactiae, S. equi, S. mitis, S. mutans, S. pyogenes, S. sanguinis, S. suis and S. uberis with that of S. pneumoniae (Figure-3B) .
Verification of the UlaR regulatory site in PulaA
To find more targets of UlaR in the D39 genome, we performed a genome-wide search with the pneumococcal UlaR regulatory site. We did find a stretch of DNA (5'-AACACAAACCTGTGTT-3') resembling the UlaR regulatory site in the intergenic region of ulaG in the genome of S. pneumoniae D39. This regulatory site is also predicted by the Regprecise database (165) for the ula operon of S. pneumoniae. However, we could not observe any expression of PulaG-lacZ in the presence of ascorbic acid as mentioned above ( Figure-2A) . Therefore, it might be that UlaR site present in the PulaG is not functional.
To further verify the UlaR regulatory site present in PulaA, transcriptional lacZfusions to 5' truncations of PulaA were constructed (Figure-3C ). β-galactosidase assays revealed that deletion of half or full of the predicted UlaR regulatory site did not show any activity in M17, AM17 (10mM Ascorbic acid + M17) or GM17 (10mM Glucose + M17) medium. However, we could observe the expression similar to that of the full-length promoter when the promoter (PulaA) was truncated only a few base pairs upstream of the predicted regulatory site (Figure-3C ). This data suggests that the UlaR regulatory site present in PulaA is functional and acts as an UlaR regulatory site in S. pneumoniae.
Discussion
The existence of several sugar-specific systems in S. pneumoniae D39 strengthens the evidence that S. pneumoniae has the ability to utilize several other carbon sources in addition to glucose which is the most favored carbon source (81, 147). There have been comprehensive studies on the regulation of many of these systems dedicated for different sugars including sucrose, maltose, galactose, raffinose and cellobiose in S. pneumoniae (67, 100-102, 156, 179, 180) . However, the role of ascorbic acid in the S. pneumoniae has not been explored yet. There are studies that indicate the use of ascorbic acid as a potential carbon source by many microorganisms (166, 168, 169, 171) . In this study, we have explored the role of the transcriptional activator (UlaR) in the activation of the ula operon in the presence of ascorbic acid in S. pneumoniae. Our bioinformatic analysis showed that the ula operon is highly conserved in all pneumococcal strains available at the KEGG website and these pneumococcal strains have a similar organization of the ula operon as the D39 strain. Conservation and similar organization of the ula operon in these pneumococcal strains does not only indicate the similar regulation pattern of the ula operon by UlaR, but also points to an important physiological function of this operon in these strains. Moreover, the ula operon and the 16bp predicted UlaR regulatory site were also found to be conserved in many other streptococci.
Therefore, UlaR most likely also acts as a transcriptional activator of the ula operon in the presence of ascorbic acid and the conserved 16bp regulatory site might act as a regulatory site for UlaR in these streptococci.
